Literature DB >> 4745250

Pulmonary disease due to Mycobacterium intracellulare.

H Yeager, J W Raleigh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4745250     DOI: 10.1164/arrd.1973.108.3.547

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  20 in total

1.  Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

Review 2.  Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Authors:  E Nuermberger; J Grosset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

Review 3.  Treatment of pulmonary disease caused by opportunist mycobacteria.

Authors:  J Banks
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

Review 4.  Risk-benefit assessment of therapies for Mycobacterium avium complex infections.

Authors:  D E Griffith
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

Review 5.  Susceptibility testing of Mycobacterium avium complex isolates.

Authors:  L Heifets
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

6.  Stimulation with cytokines enhances penetration of azithromycin into human macrophages.

Authors:  L E Bermudez; C Inderlied; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

7.  Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.

Authors:  S E Hoffner; S B Svenson; G Källenius
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

Review 8.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1974-08       Impact factor: 2.401

9.  Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium.

Authors:  W W Barrow; E L Wright; K S Goh; N Rastogi
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Macrophage uptake and retention of radiolabeled glycopeptidolipid antigens associated with the superficial L1 layer of Mycobacterium intracellulare serovar 20.

Authors:  L C Hooper; M M Johnson; V R Khera; W W Barrow
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.